Charlie Aprahamian is an Analyst at NewSpring where he is responsible for all phases throughout the lifecycle of a deal with the Firm’s dedicated healthcare strategy. Having joined NewSpring in 2023, he is responsible for new deal sourcing, underwriting, modeling, industry research, detailed due diligence, execution, and ongoing operational support to the portfolio companies.
Prior to joining NewSpring full-time, Charlie was a summer analyst with the Firm’s growth and healthcare strategies. As an undergraduate student, Charlie also worked as a growth equity intern at Blue Heron Capital, where he focused on new deal sourcing and due diligence.
Charlie received a BSBA from the University of Richmond, majoring in Economics with a concentration in Finance.